Literature DB >> 7031141

Penicillin tolerance in group B streptococci isolated from infected neonates.

K S Kim, B F Anthony.   

Abstract

Four (4%) of 100 isolates of group B streptococci from the blood or cerebrospinal fluid of infected neonates were shown to be tolerant to penicillin by significantly slower rates of killing at penicillin levels that were 16 times greater than the minimal inhibitory concentrations. Different killing rates between nontolerant and tolerant streptococci were observed with penicillin only in the logarithmic phase of growth. Nontolerant strains in the stationary phase and tolerant strains in both the logarithmic and stationary phases were killed at similar rates, which were slower than the rates for nontolerant streptococci in the logarithmic phase. When incubated with [14C]lysine-labeled preparations of cell wall, freeze-thaw extracts of tolerant strains released less radioactivity than did those of nontolerant strains. This activity of nontolerant streptococci was maximal during logarithmic growth and was heat-labile, a result which presumably reflected the activity of autolytic enzyme(s).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7031141     DOI: 10.1093/infdis/144.5.411

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

1.  A human IgG 3 is opsonic in vitro against type III group B streptococci.

Authors:  J S Kim; K S Kim; C A Wass; J A Short; D C Heiner
Journal:  J Clin Immunol       Date:  1990-05       Impact factor: 8.317

2.  Degree and stability of tolerance to penicillin in Streptococcus pyogenes.

Authors:  M F Michel; W B van Leeuwen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-03       Impact factor: 3.267

3.  Evaluation of oxacillin tolerance in Staphylococcus aureus by a novel method.

Authors:  B F Woolfrey; R T Lally; M N Ederer
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191

Review 4.  Problems in in vitro determination of antibiotic tolerance in clinical isolates.

Authors:  J C Sherris
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

5.  Reverse inoculum effect in bactericidal activity and other variables affecting killing of group B streptococci by penicillin.

Authors:  L Jokipii; P Brander; A M Jokipii
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

6.  Antibiotic resistance patterns of group B streptococci in pregnant women.

Authors:  K Berkowitz; J A Regan; E Greenberg
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

Review 7.  Neonatal sepsis. Progress in diagnosis and management.

Authors:  J W St Geme; R A Polin
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

8.  Efficacy of BMY-28142 in experimental bacteremia and meningitis caused by Escherichia coli and group B streptococci.

Authors:  K S Kim; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

9.  Ceftazidime in neonatal infections.

Authors:  D C Low; J G Bissenden; R Wise
Journal:  Arch Dis Child       Date:  1985-04       Impact factor: 3.791

10.  Streptococcus agalactiae (group B) endocarditis--a description of twelve cases and review of the literature.

Authors:  B E Scully; D Spriggs; H C Neu
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.